Difference between revisions of "Part:BBa K2534001:Design"
Line 3: | Line 3: | ||
<partinfo>BBa_K2534001 short</partinfo> | <partinfo>BBa_K2534001 short</partinfo> | ||
+ | miRNA-370 5p has been discovered to function as tumor suppressors in colorectal cancer by independently suppressing EGFR and PI3K signalling. | ||
+ | [http://2018.igem.org/Team:AFCM-Egypt# Team:AFCM-Egypt 2018] worked to do lentiviral transfection of that part into colorectal cancer cell line RKO to induce regulatory apoptosis as well as to investigate it's immune modulatory effect on TLR-9. | ||
+ | [http://2018.igem.org/Team:AFCM-Egypt# Team:AFCM-Egypt 2018] have characterized this part considering it's apoptotic effect of RKO cell lines. | ||
+ | |||
+ | For further information about demonstration of its apoptotic effect, please visit our results page | ||
+ | http://2018.igem.org/Team:AFCM-Egypt/Demonstrate | ||
+ | For further information about design of our parts, please visit our Parts & Design Page | ||
+ | http://2018.igem.org/Team:AFCM-Egypt/Parts | ||
+ | |||
+ | https://static.igem.org/mediawiki/parts/c/c1/Ch370afcm.png | ||
+ | |||
+ | This part has been modeled structurally and prepared for docking studies. | ||
+ | for more details please visit our modeling page | ||
+ | http://2018.igem.org/Team:AFCM-Egypt/Model | ||
+ | |||
+ | https://static.igem.org/mediawiki/2018/7/73/T--AFCM-Egypt--3rd_pic.png | ||
<partinfo>BBa_K2534001 SequenceAndFeatures</partinfo> | <partinfo>BBa_K2534001 SequenceAndFeatures</partinfo> | ||
===Design Notes=== | ===Design Notes=== | ||
− | IDT | + | ===Design Notes=== |
+ | this part has been synthesized through IDT offer | ||
Line 13: | Line 30: | ||
===Source=== | ===Source=== | ||
− | + | http://2018.igem.org/Team:AFCM-Egypt/Bioinformatics_Page_link | |
− | + | ||
− | + |
Latest revision as of 14:51, 17 October 2018
miRNA 370 3p
miRNA-370 5p has been discovered to function as tumor suppressors in colorectal cancer by independently suppressing EGFR and PI3K signalling. [http://2018.igem.org/Team:AFCM-Egypt# Team:AFCM-Egypt 2018] worked to do lentiviral transfection of that part into colorectal cancer cell line RKO to induce regulatory apoptosis as well as to investigate it's immune modulatory effect on TLR-9. [http://2018.igem.org/Team:AFCM-Egypt# Team:AFCM-Egypt 2018] have characterized this part considering it's apoptotic effect of RKO cell lines.
For further information about demonstration of its apoptotic effect, please visit our results page http://2018.igem.org/Team:AFCM-Egypt/Demonstrate For further information about design of our parts, please visit our Parts & Design Page http://2018.igem.org/Team:AFCM-Egypt/Parts
This part has been modeled structurally and prepared for docking studies. for more details please visit our modeling page http://2018.igem.org/Team:AFCM-Egypt/Model
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Design Notes
Design Notes
this part has been synthesized through IDT offer
Source
http://2018.igem.org/Team:AFCM-Egypt/Bioinformatics_Page_link